Pharmacokinetic evaluation of a developed nicotine transdermal system

Shaila Lewis, G. Subramanian, S. Pandey, N. Udupa

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The plasma concentration time profiles for nicotine were characterized after a single application of nicotine transdermal system to the upper fore arm of healthy smokers. A 12 cm2 system was applied for 24 h. Blood samples were withdrawn at predetermined time intervals. Plasma nicotine concentrations rose rapidly and achieved a mean Cmaxvalue of 14.5 ng/ml.The half life was estimated as 4.78 h and AUC(0-24)181.0 ng.h/ ml. The nicotine transdermal system was well tolerated. The results indicate that the system has potential usefulness in smoking cessation. The pharmacokinetic profiles of marketed patch system was compared with the developed system. Significant difference was observed in the pharmacokinetic parameters.

Original languageEnglish
Pages (from-to)309-312
Number of pages4
JournalIndian Journal of Pharmaceutical Sciences
Volume69
Issue number2
Publication statusPublished - 03-2007

Fingerprint

Nicotine
Pharmacokinetics
Smoking Cessation
Area Under Curve
Half-Life
Arm

All Science Journal Classification (ASJC) codes

  • Pharmaceutical Science

Cite this

@article{aa1105b1bf3c48ecb039298aa7243a4f,
title = "Pharmacokinetic evaluation of a developed nicotine transdermal system",
abstract = "The plasma concentration time profiles for nicotine were characterized after a single application of nicotine transdermal system to the upper fore arm of healthy smokers. A 12 cm2 system was applied for 24 h. Blood samples were withdrawn at predetermined time intervals. Plasma nicotine concentrations rose rapidly and achieved a mean Cmaxvalue of 14.5 ng/ml.The half life was estimated as 4.78 h and AUC(0-24)181.0 ng.h/ ml. The nicotine transdermal system was well tolerated. The results indicate that the system has potential usefulness in smoking cessation. The pharmacokinetic profiles of marketed patch system was compared with the developed system. Significant difference was observed in the pharmacokinetic parameters.",
author = "Shaila Lewis and G. Subramanian and S. Pandey and N. Udupa",
year = "2007",
month = "3",
language = "English",
volume = "69",
pages = "309--312",
journal = "Indian Journal of Pharmaceutical Sciences",
issn = "0250-474X",
publisher = "Medknow Publications and Media Pvt. Ltd",
number = "2",

}

Pharmacokinetic evaluation of a developed nicotine transdermal system. / Lewis, Shaila; Subramanian, G.; Pandey, S.; Udupa, N.

In: Indian Journal of Pharmaceutical Sciences, Vol. 69, No. 2, 03.2007, p. 309-312.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Pharmacokinetic evaluation of a developed nicotine transdermal system

AU - Lewis, Shaila

AU - Subramanian, G.

AU - Pandey, S.

AU - Udupa, N.

PY - 2007/3

Y1 - 2007/3

N2 - The plasma concentration time profiles for nicotine were characterized after a single application of nicotine transdermal system to the upper fore arm of healthy smokers. A 12 cm2 system was applied for 24 h. Blood samples were withdrawn at predetermined time intervals. Plasma nicotine concentrations rose rapidly and achieved a mean Cmaxvalue of 14.5 ng/ml.The half life was estimated as 4.78 h and AUC(0-24)181.0 ng.h/ ml. The nicotine transdermal system was well tolerated. The results indicate that the system has potential usefulness in smoking cessation. The pharmacokinetic profiles of marketed patch system was compared with the developed system. Significant difference was observed in the pharmacokinetic parameters.

AB - The plasma concentration time profiles for nicotine were characterized after a single application of nicotine transdermal system to the upper fore arm of healthy smokers. A 12 cm2 system was applied for 24 h. Blood samples were withdrawn at predetermined time intervals. Plasma nicotine concentrations rose rapidly and achieved a mean Cmaxvalue of 14.5 ng/ml.The half life was estimated as 4.78 h and AUC(0-24)181.0 ng.h/ ml. The nicotine transdermal system was well tolerated. The results indicate that the system has potential usefulness in smoking cessation. The pharmacokinetic profiles of marketed patch system was compared with the developed system. Significant difference was observed in the pharmacokinetic parameters.

UR - http://www.scopus.com/inward/record.url?scp=34347404526&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34347404526&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:34347404526

VL - 69

SP - 309

EP - 312

JO - Indian Journal of Pharmaceutical Sciences

JF - Indian Journal of Pharmaceutical Sciences

SN - 0250-474X

IS - 2

ER -